MICA AI Medical is an innovative digital health company based in Israel.  The company developed AI-based Machine Learning systems to aid early diagnosis and detection of breast cancer. The product line includes the Denise and MammoCompare systems.

The Denise analyzes Contrast Enhanced Spectral Mammography (CESM) using a proprietary algorithm that aids in estimating the likelihood that the tumor being analyzed may be malignant, in an effort to reduce the unwarranted large number of cases referred for biopsy.

The MammoCompare system performs automatic comparisons of serial mammograms of the same person, to aid radiologists identify small changes over time that are often missed by the naked eye.

The MICA system received regulatory approval from the Israel Ministry of Health, and received ISO 13485 certification and CFS Clearance. The company plans to apply for FDA 510(k) Clearance by the end of 2021.

Our research and validation is done together with The Sheba Medical Center, and Prof. Sklair, the head of the breast cancer division, serves as medical advisor for MICA. Together, we've completed the  clinical validation and the results ARE AMAZING – the platform increased the accuracy rate and decreased the number of unnecessary biopsies (The platform is clinically validated- validation conducted at SHEBA medical center with 400 cases, showed an increase of mammography accuracy to ~92%, and decreased unnecessary biopsies by 35%.).

Additional information may be found as follows

Company website : https://micamedic.com/

Presentations: https://youtu.be/1kkW-Mclrxk ,  https://youtu.be/tIlGy6cKesk